Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) insider Nicholas Hollmeyer Lynton sold 6,464 shares of the firm’s stock in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $3.67, for a total value of $23,722.88. Following the transaction, the insider now owns 91,771 shares of the company’s stock, valued at $336,799.57. This trade represents a 6.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Cardlytics Trading Down 8.4 %
CDLX opened at $3.49 on Tuesday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The firm has a 50-day moving average price of $3.91 and a two-hundred day moving average price of $4.81. Cardlytics, Inc. has a 1-year low of $2.89 and a 1-year high of $20.52. The stock has a market capitalization of $177.37 million, a PE ratio of -0.57 and a beta of 1.53.
Cardlytics (NASDAQ:CDLX – Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.33) by $0.18. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The firm had revenue of $67.06 million during the quarter, compared to analysts’ expectations of $57.77 million. During the same period in the previous year, the business posted ($0.26) EPS. The company’s quarterly revenue was down 15.1% compared to the same quarter last year. As a group, equities analysts anticipate that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on CDLX. Evercore ISI assumed coverage on Cardlytics in a report on Friday, October 11th. They set an “in-line” rating and a $4.00 price objective for the company. Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Thursday, November 7th. Finally, Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $6.92.
View Our Latest Research Report on Cardlytics
About Cardlytics
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
See Also
- Five stocks we like better than Cardlytics
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- How to Use the MarketBeat Stock Screener
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- What Makes a Stock a Good Dividend Stock?
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.